The largest database of trusted experimental protocols

3 protocols using sc 15363

1

Quantification of EV Markers in MIA PaCa-2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
EVs were collected from 50mL of MIA PaCa-2 cells supernatant cultured for 72h in RPMI medium supplemented with EVs-depleted FBS. EVs isolation was performed as previously described. Then, EVs pellet was resuspended in 100μL of PBS 1X and divided into four conditions for the analysis of CD63, CD81, CD82 and Rab5. A similar protocol to the one performed for the analysis of Evs by flow cytometry was done until detection in ImageStream× MarkII Imaging Flow Citometry (Luminex Amnis Image Stream Multispectral Imaging Flow Cytometer, RRID:SCR_018589). Primary antibodies used were: anti-CD63 1:400 (Santa Cruz Biotechnology Cat# sc-15363, RRID:AB_648179), anti-CD81 1:400 (Abcam Cat# ab109201, RRID:AB_10866464), anti-CD82 1:400 (Abcam Cat# ab59509, RRID:AB_2076398) and anti-Rab5 1:400 (Cell Signaling Technology Cat# 46449, RRID:AB_2799303). Secondary antibodies used were: Donkey anti-mouse IgG Alexa Fluor 488 1:500 (Molecular Probes Cat# A-21202, RRID:AB_141607) and Goat anti-rabbit IgG Alexa Fluor 488 1:500 (Thermo Fisher Scientific Cat# A-11034, RRID:AB_2576217). For each sample, control refers to EVs incubated with secondary antibody only.
+ Open protocol
+ Expand
2

Exosome and Cell Lysate Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in lysis buffer supplemented with PIs, for 15 min at 4 °C, centrifuged at 12000g for 15 min at 4 °C and the supernatant collected and stored at −20 °C until further use. EV (exosomes) and cell lysate protein concentration was measured using Pierce BCA Protein Assay Kit (Thermo Scientific MA, USA).
For immunoblotting, total EV, exosomal, and viral proteins or 30 μg of cell lysates were separated by 12% SDS-PAGE and transferred to PVDF membrane (Millipore). Goat polyclonal antibodies against Hsc70 (sc-1059, Santa Cruz Biotechnology, CA, USA), actin (sc-1615), rabbit polyclonal against calnexin (sc-11,397), CD63 (sc-15,363), alpha-tubulin (ab4074, Abcam, UK), VSV-G (ab1874, Abcam), HIV-1 Nef (NIH AIDS Reagent Program, 2949), and HIV-1 gp120 (NBP1–76371, Novus Biologicals, CO, USA); or mouse monoclonal against acetylcholinesterase (AChE, MAB303, Millipore), flotillin, (610820, BD Bioscience, NJ, USA), GFP (sc-9996), p24/Gag (ab9071, Abcam), cytochrome c (556432, BD Biosciences), and Alix (2171S, Cell Signaling, MA, USA) were used as the primary antibodies; and appropriate HRP-conjugated anti-goat, anti-rabbit, or anti-mouse (Jackson Immunoresearch, PA, USA) were used as the secondary antibodies. Membranes were developed by SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific).
+ Open protocol
+ Expand
3

Imaging Flow Cytometry of EV Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
EVs were collected from 50 mL of MIA PaCa-2 cell supernatant cultured for 72 hours in RPMI medium supplemented with EV-depleted FBS. EV isolation was performed as previously described. Then, EV pellet was resuspended in 100 µL of PBS 1× and divided into four conditions for the analysis of CD63, CD81, CD82 and Rab5. A similar protocol to the one performed for the analysis of Evs by flow cytometry was done until detection in ImageStreamx MarkII Imaging Flow Citometry (Luminex Amnis Image Stream Multispectral Imaging Flow Cytometer, RRID:SCR_018589). Primary antibodies used were anti-CD63 1:400 (Santa Cruz Biotechnology Cat# sc-15363, RRID:AB_648179), anti-CD81 1:400 (Abcam Cat# ab109201, RRID:AB_10866464), anti-CD82 1:400 (Abcam Cat# ab59509, RRID:AB_2076398) and anti-Rab5 1:400 (Cell Signalling Technology Cat# 46449, RRID:AB_2799303). Secondary antibodies used were Donkey antimouse IgG Alexa Fluor 488 1:500 (Molecular Probes Cat# A-21202, RRID:AB_141607) and goat antirabbit IgG Alexa Fluor 488 1:500 (Thermo Fisher Scientific Cat# A-11034, RRID:AB_2576217). For each sample, control refers to EVs incubated with secondary antibody only.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!